We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Artel Expands Portfolio with STRATEC Partnership for Automation Technology

By LabMedica International staff writers
Posted on 16 Feb 2015
Artel (Westbrook, Maine, USA), a leader in laboratory liquid handling measurement systems, and STRATEC Biomedical AG (Birkenfeld, Germany), a leader in automated systems for clinical diagnostics and biotechnology, have entered into a strategic partnership for STRATEC’s innovative “Tholos” technology, which measures liquid and solid contents of 96- and 384-well microplates. More...


Artel will be the exclusive marketer for the “Tholos” technology, under the name Artel “SDS” - Sample Detection System, in the United States, Canada, Germany, Australia, and Switzerland. The companies will also work together on future technology enhancements for the product.

Designed to improve in-line process efficiency and quality assurance in compound management and storage, SDS can also assess the delivery accuracy and precision of automated liquid handlers. By sealing and pressurizing individual microplate wells, SDS measures their contents, down to 1% of the potential volume, regardless of the shape, material, or color of the well or tube. It is an ideal complement to Artel’s “MVS” - Multichannel Verification System, which verifies aqueous-based volume transfers.

“This system closes a gap in automation processes,” said Marcus Wolfinger, chairman, Board of Management, STRATEC, “We are very proud to have gained Artel, the global market leader in liquid handling quality assurance, as a partner.”

“Our customers will benefit from this powerful technology, which further enhances their ability to ensure high-quality results,” said Kirby Pilcher, president, Artel, “The partnership with STRATEC, a worldwide leader in their field, has resulted in a perfect addition to Artel’s portfolio of liquid handling quality assurance products and services.”

Related Links:

Artel
Stratec Biomedical



New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
Serological Pipet Controller
PIPETBOY GENIUS
New
Candida Glabrata Test
ELIchrom Glabrata
New
Automated Biochemical Analyzer
iBC 900
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: The RNA-seq based diagnostic test for pediatric leukemia ensures better outcomes for children with this common cancer (Photo courtesy of Qlucore)

RNA-Seq Based Diagnostic Test Enhances Diagnostic Accuracy of Pediatric Leukemia

A new unique test is set to reshape the way Acute Lymphoblastic Leukemia (BCP-ALL) samples can be analyzed. Qlucore (Lund, Sweden) has launched the first CE-marked RNA-seq based diagnostic test for pediatric... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.